Enovis makes binding offer to acquire eCential Robotics

Enovis Corporation (NYSE: ENOV) has submitted a binding offer to acquire eCential Robotics, a French surgical robotics company headquartered in Gières, France, with U.S. commercial operations in Franklin, Tennessee, according to a press release.

The transaction is expected to close in the fourth quarter of 2026, subject to regulatory approvals. Before a definitive purchase agreement is signed, the parties must complete an information and consultation process with eCential Robotics' works council under French law.

eCential Robotics develops the Op.n® platform, which combines surgical navigation and active robotics in a single architecture. The platform has received FDA 510(k) clearance for spine surgery in the United States.

Enovis said the acquisition is intended to expand its ASTRA™ enabling technology ecosystem with robotic automation capabilities. Enovis CEO Damien McDonald said the eCential Robotics platform "is a natural complement to our ARVIS® Augmented Reality System, and will give surgeons a broader set of robotic solutions."

eCential Robotics CEO Clément Vidal said the company plans to continue supporting collaboration with spine implant partners following the transaction.

Apparius served as exclusive financial advisor to eCential Robotics. Goodwin France and Cabinet Franck Robert acted as legal counsel to eCential Robotics.

You May Also Be Interested In

• Click Holdings reports record revenue of HK$135.2M for fiscal 2026
• Fireblocks Denies In Talks To Be Acquired By Visa - Coindesk
• Hyperfine portable MRI gets CE mark, expands in Europe